Biotech
Vertex Pharmaceuticals Incorporated
1
Articles
Primary Subject
Top Role
Mar 28, 2026
First Mention
Mar 28, 2026
Last Mention
1.83
Relevance Score
Coverage Timeline
March 2026
CRISPR in the Real World: Vertex and CRISPR Therapeutics Shake Up Rare Disease Economics with Exa-cel
The Week
Primary Subject
Mar 28, 2026
Vertex and CRISPR Therapeutics didn’t just win the FDA’s nod for exa-cel, their CRISPR-based sickle cell therapy, they made a statement with the $2.2 million list price.